| Date Filed | Type | Description |
| 05/12/2023 |
4
| Rollins Emily (Director) has filed a Form 4 on Science 37 Holdings, Inc.|
Txns:
| Exercised 40,983 restricted stock units
@ $0
Granted 494,853 restricted stock units
@ $0 |
|
| 05/10/2023 |
4
| Rollins Emily (Director) has filed a Form 4 on Dolby Laboratories, Inc.|
Txns:
| Sold 1,000 shares
@ $84.7, valued at
$84.7k
|
|
| 05/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/23/2023 |
4
| Rollins Emily (Director) has filed a Form 4 on Xometry, Inc.|
Txns:
| Granted 7,041 shares
@ $0 |
|
| 02/09/2023 |
4
| Rollins Emily (Director) has filed a Form 4 on Dolby Laboratories, Inc.|
Txns:
| Granted 3,296 shares
@ $0 |
|
| 01/04/2023 |
4
| Rollins Emily (Director) has filed a Form 4 on Xometry, Inc.|
Txns:
| Sold 2,000 shares
@ $32.32, valued at
$64.6k
Exercised 2,000 options to buy
@ $12.32, valued at
$24.6k
|
|
| 11/28/2022 |
4
| Rollins Emily (Director) has filed a Form 4 on Xometry, Inc.|
Txns:
| Sold 1,859 shares
@ $42.361, valued at
$78.7k
Sold 141 shares
@ $42.85, valued at
$6k
Exercised 2,000 options to buy
@ $12.32, valued at
$24.6k
|
|
| 10/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2022 |
4
| Rollins Emily (Director) has filed a Form 4 on Xometry, Inc.|
Txns:
| Sold 1,148 shares
@ $58.9294, valued at
$67.7k
Sold 722 shares
@ $59.7768, valued at
$43.2k
Sold 130 shares
@ $60.5925, valued at
$7.9k
Exercised 2,000 options to buy
@ $12.32, valued at
$24.6k
|
|
| 08/30/2022 |
4
| Rollins Emily (Director) has filed a Form 4 on Xometry, Inc.|
Txns:
| Sold 1,777 shares
@ $46.0257, valued at
$81.8k
Sold 223 shares
@ $47.1785, valued at
$10.5k
Exercised 2,000 options to buy
@ $12.32, valued at
$24.6k
|
|
| 08/12/2022 |
4
| Rollins Emily (Director) has filed a Form 4 on Dolby Laboratories, Inc.|
Txns:
| Sold 1,000 shares
@ $80, valued at
$80k
|
|
| 08/12/2022 |
4
| Rollins Emily (Director) has filed a Form 4 on Xometry, Inc.|
Txns:
| Sold 10,000 shares
@ $50, valued at
$500k
Exercised 10,000 options to buy
@ $12.32, valued at
$123.2k
|
|
| 05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2022 |
4
| Rollins Emily (Director) has filed a Form 4 on Dolby Laboratories, Inc.|
Txns:
| Granted 2,783 shares
@ $0 |
|
| 10/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/08/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/26/2021 |
4
| Rollins Emily (Director) has filed a Form 4 on Dolby Laboratories, Inc.|
Txns:
| Granted 2,462 shares
@ $0 |
|
| 02/26/2021 |
3/A
| Rollins Emily (Director) has filed a Form 3/A on Dolby Laboratories, Inc. |
| 02/26/2021 |
3
| Rollins Emily (Director) has filed a Form 3 on Dolby Laboratories, Inc. |